References
- Alberti, K.G., et al., 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120 (16), 1640–1645.
- Aneja, A., et al., 2008. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. The American journal of medicine, 121 (9), 748–757.
- Arjmand, M.H., 2020. The association between visceral adiposity with systemic inflammation, oxidative stress, and risk of post-surgical adhesion. Archives of physiology and biochemistry, 1–6. doi:10.1080/13813455.2020.1733617
- Aronson, D., 2003. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. Journal of hypertension, 21 (1), 3–12.
- Arung, W., Meurisse, M., and Detry, O., 2011. Pathophysiology and prevention of postoperative peritoneal adhesions. World journal of gastroenterology, 17 (41), 4545–4553.
- Bethesda, M., 2014. USRDS annual data report: epidemiology of kidney disease in the United States. United States Renal Data System, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 188–210.
- Bourne, R.R., et al., 2013. Causes of vision loss worldwide, 1990–2010: a systematic analysis. The Lancet. Global health, 1 (6), e339–e349.
- Branton, M.H. and Kopp, J.B., 1999. TGF-β and fibrosis. Microbes and infection, 1 (15), 1349–1365.
- Cantley, L.C., 2002. The phosphoinositide 3-kinase pathway. Science (New York, NY), 296 (5573), 1655–1657.
- Chung, S.S., et al., 2003. Contribution of polyol pathway to diabetes-induced oxidative stress. Journal of the American society of nephrology, 14 (8 Suppl. 3), S233–S236.
- Coccolini, F., et al., 2013. Peritoneal adhesion index (PAI): proposal of a score for the “ignored iceberg” of medicine and surgery. World journal of emergency surgery, 8 (1), 6.
- Coleman, M., McLain, A., and Moran, B., 2000. Impact of previous surgery on time taken for incision and division of adhesions during laparotomy. Diseases of the colon & rectum, 43 (9), 1297–1299.
- Diamond, M.P. and Freeman, M.L., 2001. Clinical implications of postsurgical adhesions. Human reproduction update, 7 (6), 567–576.
- Dobbs, R., et al., 1975. Glucagon: role in the hyperglycemia of diabetes mellitus. Science (New York, NY), 187 (4176), 544–547.
- Donnez, J., et al., 2016. Oxidative stress in the pelvic cavity and its role in the pathogenesis of endometriosis. Fertility and sterility, 106 (5), 1011–1017.
- Dua, M.M., et al., 2010. Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease. Surgery, 148 (2), 429–435.
- Esposito, K., et al., 2002. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation, 106 (16), 2067–2072.
- Esposito, K., Marfella, R., and Giugliano, D., 2003. Stress hyperglycemia, inflammation, and cardiovascular events. Diabetes care, 26 (5), 1650–1651.
- Feener, E.P. and King, G.L., 1997. Vascular dysfunction in diabetes mellitus. The Lancet, 350, S9–S13.
- Fortin, C.N., Saed, G.M., and Diamond, M.P., 2015. Predisposing factors to post-operative adhesion development. Human reproduction update, 21 (4), 536–551.
- Fotev, Z., Whitaker, D., and Papadimitriou, J., 1987. Role of macrophages in mesothelial healing. The journal of pathology, 151 (3), 209–219.
- Goldin, A., et al., 2006. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation, 114 (6), 597–605.
- Guimarães, E.L., et al., 2010. Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells. Journal of hepatology, 52 (3), 389–397.
- Hayden, M.R., et al., 2008. Attenuation of endocrine–exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities. Journal of the cardiometabolic syndrome, 3 (4), 234–243.
- Hellebrekers, B. and Kooistra, T., 2011. Pathogenesis of postoperative adhesion formation. The British journal of surgery, 98 (11), 1503–1516.
- Herder, C., et al., 2005. Inflammation and type 2 diabetes: results from KORA Augsburg. Das gesundheitswesen, 67 (S 01), 115–121.
- Hoek, T.L.V., et al., 1998. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. The journal of biological chemistry, 273 (29), 18092–18098.
- Holmdahl, L., et al., 1996. Fibrinolysis in human peritoneum during operation. Surgery, 119 (6), 701–705.
- Honiden, S. and Gong, M.N., 2009. Diabetes, insulin, and development of acute lung injury. Critical care medicine, 37 (8), 2455–2464.
- Hughes, K., et al., 1998. Cardiovascular risk factors in non-insulin-dependent diabetics compared to non-diabetic controls: a population-based survey among Asians in Singapore. Atherosclerosis, 136 (1), 25–31.
- Hynes, R.O., 2009. The extracellular matrix: not just pretty fibrils. Science (New York, NY), 326 (5957), 1216–1219.
- Ignotz, R.A. and Massagué, J., 1987. Cell adhesion protein receptors as targets for transforming growth factor-beta action. Cell, 51 (2), 189–197.
- Inoguchi, T., et al., 1992. Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proceedings of the national academy of sciences of the United States of America, 89 (22), 11059–11063.
- Ishii, H., et al., 1996. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science (New York, NY), 272 (5262), 728–731.
- Kagami, S., et al., 1996. Transforming growth factor-beta (TGF-beta) stimulates the expression of beta1 integrins and adhesion by rat mesangial cells. Experimental cell research, 229 (1), 1–6.
- Karamanos, E., et al., 2016. Diabetes mellitus in patients presenting with adhesive small bowel obstruction: delaying surgical intervention results in worse outcomes. World journal of surgery, 40 (4), 863–869.
- King, G.L. and Loeken, M.R., 2004. Hyperglycemia-induced oxidative stress in diabetic complications. Histochemistry and cell biology, 122 (4), 333–338.
- Kirstein, M., et al., 1990. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proceedings of the national academy of sciences of the United States of America, 87 (22), 9010–9014.
- Kiryu, K., et al., 1994. Phenotypic expressions of type I, III, IV, V, and VI collagens in patients with diabetic nephropathy: immunohistochemical comparison between HD and non-HD patients. Nihon jinzo gakkai shi, 36 (4), 365–373.
- Kitagawa, N., et al., 2006. Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients. Diabetes research and clinical practice, 73 (2), 150–157.
- Ko, S.H., et al., 2006. High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. Journal of cellular biochemistry, 98 (2), 343–355.
- Kruithof, E., 1988. Plasminogen activator inhibitors—a review. Enzyme, 40 (2–3), 113–121.
- Kuhad, A., et al., 2009. Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits. Pharmacology, biochemistry, and behavior, 92 (2), 251–259.
- Li, J.H., et al., 2004. Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease. FASEB journal, 18 (1), 176–178.
- Liberek, T., et al., 1996. Adherence of neutrophils to human peritoneal mesothelial cells: role of intercellular adhesion molecule-1. Journal of the American society of nephrology, 7 (2), 208–217.
- Lin, Y., et al., 2005. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. The journal of biological chemistry, 280 (6), 4617–4626.
- Liu, Y., Fiskum, G., and Schubert, D., 2002. Generation of reactive oxygen species by the mitochondrial electron transport chain. Journal of neurochemistry, 80 (5), 780–787.
- López-Novoa, J.M. and Nieto, M.A., 2009. Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO molecular medicine, 1 (6–7), 303–314.
- Martinez-Hernandez, A. and Amenta, P.S., 1995. The extracellular matrix in hepatic regeneration. The FASEB journal, 9 (14), 1401–1410.
- McCord, M., 1980. A superoxide-activated chemotactic factor and its role in the inflammatory process. Agents and actions, 10 (6), 522–527.
- Menzies, D., 1992. Peritoneal adhesions. Incidence, cause, and prevention. Surgery annual, 24, 27.
- Menzies, D. and Ellis, H., 1990. Intestinal obstruction from adhesions – how big is the problem? Annals of the royal college of surgeons of England, 72 (1), 60–63.
- Mittal, M., et al., 2014. Reactive oxygen species in inflammation and tissue injury. Antioxidants & redox signaling, 20 (7), 1126–1167.
- Muñoz, A. and Costa, M., 2013. Nutritionally mediated oxidative stress and inflammation. Oxidative medicine and cellular longevity, 2013, 610950.
- Mutsaers, S.E., et al., 2016. Mesothelial cells and peritoneal homeostasis. Fertility and sterility, 106 (5), 1018–1024.
- Nabel, E.G., et al., 1993. Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proceedings of the national academy of sciences of the United States of America, 90 (22), 10759–10763.
- Nishikawa, T., et al., 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404 (6779), 787–790.
- Ott, C., et al., 2014. Role of advanced glycation end products in cellular signaling. Redox biology, 2, 411–429.
- Parker, M., et al., 2005. The SCAR‐3 study: 5‐year adhesion‐related readmission risk following lower abdominal surgical procedures. Colorectal disease, 7 (6), 551–558.
- Pickup, J., et al., 1997. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia, 40 (11), 1286–1292.
- Poli, G. and Parola, M., 1997. Oxidative damage and fibrogenesis. Free radical biology & medicine, 22 (1–2), 287–305.
- Radak, Z., Chung, H.Y., and Goto, S., 2005. Exercise and hormesis: oxidative stress-related adaptation for successful aging. Biogerontology, 6 (1), 71–75.
- Raftery, A., 1979. Regeneration of peritoneum: a fibrinolytic study. Journal of anatomy, 129 (Pt 3), 659–664.
- Ramos-Levi, A.M., et al., 2013. Remission of type 2 diabetes mellitus should not be the foremost goal after bariatric surgery. Obesity surgery, 23 (12), 2020–2025.
- Regan, T.J., et al., 1981. Myocardial composition and function in diabetes. The effects of chronic insulin use. Circulation research, 49 (6), 1268–1277.
- Rolo, A.P. and Palmeira, C.M., 2006. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicology and applied pharmacology, 212 (2), 167–178.
- Roymans, D., et al., 2001. Protein tyrosine kinase-dependent regulation of adenylate cyclase and phosphatidylinositol 3-kinase activates the expression of glial fibrillary acidic protein upon induction of differentiation in rat c6 glioma. Cell biology international, 25 (5), 467–474.
- Sabri, M.I., 1984. In vitro effect of n-hexane and its metabolites on selected enzymes in glycolysis, pentose phosphate pathway and citric acid cycle. Brain research, 297 (1), 145–150.
- Sahai, A., et al., 2004. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. American journal of physiology. Gastrointestinal and liver physiology, 287 (5), G1035–G1043.
- Santos, S., et al., 2017. Hyperglycemic condition during puberty increases collagen fibers deposition in the prostatic stroma and reduces MMP-2 activity. Biochemical and biophysical research communications, 493 (4), 1581–1586.
- Schalkwijk, C.G., Ter Wee, P.M., and Stehouwer, C.D., 2005. Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction. Annals of the New York academy of sciences, 1043, 662–670.
- Schmidt, A.M., et al., 1995. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. The journal of clinical investigation, 96 (3), 1395–1403.
- Scott-Coombes, D.M., Whawell, S.A., and Thompson, J.N., 1995. The operative peritoneal fibrinolytic response to abdominal operation. The European journal of surgery = acta chirurgica, 161 (6), 395–399.
- Seneviratne, B.I., 1977. Diabetic cardiomyopathy: the preclinical phase. British medical journal, 1 (6074), 1444–1446.
- Sivakumar, P. and Das, A., 2008. Fibrosis, chronic inflammation and new pathways for drug discovery. Inflammation research, 57 (9), 410–418.
- Stetler-Stevenson, W.G., 1996. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. The American journal of pathology, 148 (5), 1345–1350.
- Sudamrao Garud, M. and Anant Kulkarni, Y., 2014. Hyperglycemia to nephropathy via transforming growth factor beta. Current diabetes reviews, 10 (3), 182–189.
- Sulaiman, H., et al., 2000. Growth of nerve fibres into murine peritoneal adhesions. The journal of pathology, 192 (3), 396–403.
- Sulaiman, H., et al., 2002. Role of plasminogen activators in peritoneal adhesion formation. Biochemical society transactions, 30 (2), 126–131.
- Talakatta, G., et al., 2018. Diabetes induces fibrotic changes in the lung through the activation of TGF-β signaling pathways. Scientific reports, 8 (1), 11920.
- Vlassara, H. and Striker, G.E., 2013. Advanced glycation endproducts in diabetes and diabetic complications. Endocrinology and metabolism clinics of North America, 42 (4), 697–719.
- Vlassara, H., et al., 1992. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proceedings of the national academy of sciences of the United States of America, 89 (24), 12043–12047.
- Ward, B.C. and Panitch, A., 2011. Abdominal adhesions: current and novel therapies. Journal of surgical research, 165 (1), 91–111.
- Wautier, J., et al., 1994. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proceedings of the national academy of sciences of the United States of America, 91 (16), 7742–7746.
- Yamagishi, S-i., et al., 2008. Agents that block advanced glycation end product (AGE)–RAGE (receptor for AGEs)–oxidative stress system: a novel therapeutic strategy for diabetic vascular complications. Expert opinion on investigational drugs, 17 (7), 983–996.
- Yan, S.D., et al., 1994. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. The journal of biological chemistry, 269 (13), 9889–9897.
- Zhang, M., et al., 2006. Glycated proteins stimulate reactive oxygen species production in cardiac myocytes. Circulation, 113 (9), 1235–1243.
- Zhao, J., Randive, R., and Stewart, J.A., 2014. Molecular mechanisms of AGE/RAGE-mediated fibrosis in the diabetic heart. World journal of diabetes, 5 (6), 860–867.
- Zhu, D., et al., 1994. Application of electron microscopic immunocytochemistry to the human kidney: distribution of type IV and type VI collagen in normal human kidney. The journal of histochemistry and cytochemistry, 42 (5), 577–584.